CRSSX | FSSNX | CRSSX / FSSNX | |
Total Expense Ratio | 0.28 | 0.03 | 1,120% |
Annual Report Gross Expense Ratio | 0.28 | 0.03 | 1,120% |
Fund Existence | 4 years | 14 years | - |
Gain YTD | 3.650 | 7.731 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 565M | 27.7B | 2% |
Annual Yield % from dividends | 1.47 | 0.84 | 175% |
Returns for 1 year | 6.72 | 13.29 | 51% |
Returns for 3 years | 25.97 | 39.27 | 66% |
Returns for 5 years | N/A | 61.93 | - |
Returns for 10 years | N/A | 101.99 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CIK | 2.97 | 0.01 | +0.51% |
Credit Suisse Asset Management Income Fund | |||
SPTI | 29.00 | 0.11 | +0.36% |
SPDR® Portfolio Intmdt Term Trs ETF | |||
VSHY | 21.97 | N/A | +0.02% |
Virtus Newfleet Short Dur Hi Yld Bd ETF | |||
PPH | 89.03 | N/A | N/A |
VanEck Pharmaceutical ETF | |||
USOY | 8.15 | -0.13 | -1.57% |
Defiance Oil Enhanced Options Income ETF |